Active Equities to Watch -- Research on CSX Corp., Gerdau, Walter Energy, and DARA BioSciences

LONDON, June 2, 2014 /PRNewswire/ --

On Friday, May 30, 2014, the NASDAQ Composite ended at 4,242.62, down 0.13%, the Dow Jones Industrial Average advanced 0.11%, to finish the day at 16,717.17, and the S&P 500 closed at 1,923.57, up 0.18%. The session saw a positive impact from Utilities, Consumer Staples, and Telecommunication Services sectors along with a drag from Energy and Materials sectors. Investor-Edge has initiated coverage on the following equities: CSX Corp. (NYSE: CSX), Gerdau S.A. (NYSE: GGB), Walter Energy Inc. (NYSE: WLT) and DARA BioSciences Inc. (NASDAQ: DARA). Free technical research on CSX, GGB, WLT and DARA can be downloaded upon signing up at:

http://www.investor-edge.com/3274-register

CSX Corp. fluctuated between $29.30 and $29.58 before ending the day 0.41% lower at $29.40. The company's stock reported a trading volume of 9.64 million shares on Friday, which was above its three months average volume of 6.02 million shares. CSX Corp.'s shares have gained 0.27% in the previous three trading sessions, 4.18% in the last one month, and 2.19% on YTD basis. The S&P 500 Industrials Sector Index has gained 4.02% in the previous three months, while the S&P 500 has advanced 3.45% during the same period. The stock is trading above its 50-day and 200-day moving averages. Moreover, CSX Corp.'s 50-day moving average of $28.66 is greater than its 200-day moving average of $27.32. Additionally, the company's stock traded at a PE ratio of 16.64 and has a Relative Strength Index (RSI) of 58.56. Sign up today to read free research on CSX at:

http://www.investor-edge.com/3274-CSX-02Jun2014.pdf

On Friday, Gerdau S.A.'s stock fell 3.57%, closing the day at $5.94. The stock recorded a trading volume of 7.78 million shares, above its three months average volume of 5.64 million shares. The stock oscillated between $5.93 and $6.07 during the trading session. Gerdau S.A.'s shares have lost 3.57% in the previous three trading sessions, 1.16% in the last one month, and 24.23% since the start of this year. The S&P 500 Materials Sector Index has gained 3.01% in the last one month, while the S&P 500 Index has advanced 2.26% during the same period. Gerdau S.A.'s stock is trading below its 50-day and 200-day moving averages of $6.22 and $7.07, respectively. Moreover, shares of the company have an RSI of 35.27. Sign up today to read free research on GGB at:

http://www.investor-edge.com/3274-GGB-02Jun2014.pdf

Walter Energy Inc.'s stock finished Friday's session 4.13% lower at $4.88. A total of 9.06 million shares were traded, which was above its three months average volume of 6.00 million shares. The stock vacillated between $4.86 and $5.19 during the session. Over the previous three trading sessions and over the last one month, Walter Energy Inc.'s shares have lost 11.43% and 32.22%, respectively. Further, the company's stock has declined 70.66% in on YTD basis. The S&P 500 Materials Sector Index has gained 1.03% in the previous three trading sessions, while the S&P 500 Index has advanced 0.61% during the same period. The company's shares are trading below their 50-day moving average. Moreover, the stock's 200-day moving average of $12.08 is greater than its 50-day moving average of $7.08. Further, Walter Energy Inc.'s stock has an RSI of 21.38. Sign up today to read free research on WLT at:

http://www.investor-edge.com/3274-WLT-02Jun2014.pdf

On Friday, shares in DARA Biosciences Inc. recorded a trading volume of 8.04 million shares, which was much above its three months average volume of 0.68 million shares. The stock ended the day at $1.19, which was 25.63% lower than its previous day's closing price of $1.60, and registered an intraday range of $1.13 and $1.26. DARA Biosciences Inc.'s shares have gained 8.18% in the previous three trading sessions, while the stock has declined 30.81% in the last one month and 55.93% on YTD basis. The company's stock is trading below its 50-day and 200-day moving averages of $2.05 and $2.60, respectively. Furthermore, shares of the company have an RSI of 42.39. On the same day, DARA Biosciences Inc. announced the pricing of approximately $12.5 million public offering, which is expected to take place on or about June 4, 2014, subject to the satisfaction of customary closing conditions. Sign up today to read free research on DARA at:

http://www.investor-edge.com/3274-DARA-02Jun2014.pdf


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

Investor-Edge.com

SOURCE Investor-Edge

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED